Search results
Blenrep-Based Regimen Yields PFS Benefit in Relapsed/Refractory Myeloma
MedPage Today· 3 days agoProgression-free survival (PFS) was significantly higher with belantamab mafodotin (belamaf;...
New Gene Tests Can Predict if a Drug Will Work for a Patient
Medscape· 5 days agoWhat if there were tests that could tell you whether the following drugs were a good match for your...
Jasper Therapeutics to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI...
Benzinga· 6 days agoREDWOOD CITY, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ:JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting
Cancer Survivors Are Sharing The Weird Symptom That Made Them Go "Hm, Something Isn't Right Here,"...
BuzzFeed via Yahoo News· 4 days ago"If they tell you it might be cancer and have you come back in a couple of weeks for a biopsy, say...